The University of Hawaiʻi at Mānoa is a public land-grant research university in Mānoa, a neighborhood in Honolulu, Hawaii, United States. It is the flagship campus of the University of Hawaiʻi system and houses the main offices of the system.

During the past decade, University of Hawaii conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 36 clinical trials were completed, i.e. on average, 189.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Hawaii" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 47 trials, followed by "University of Hawaii" with 14 trials sponsored, "Children's Oncology Group" with 11 trials sponsored, "National Cancer Institute (NCI)" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Hawaii" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "University of Hawaii" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "University of Hawaii" are "HIV Infections" (52 trials), "Breast Cancer" (5 trials), "Diabetes Mellitus, Type 2" (4 trials), "Contraception" (3 trials) and "HIV Seronegativity" (3 trials). Many other conditions were trialed in "University of Hawaii" in a lesser frequency.

Most popular intervention types in "University of Hawaii" are "Drug" (75 trials), "Other" (18 trials), "Biological" (14 trials), "Behavioral" (13 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (10 trials), "Indinavir sulfate" (8 trials), "Zidovudine" (7 trials), "cyclophosphamide" (7 trials) and "Lamivudine" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Hawaii" are 98 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 17 active trials in "University of Hawaii". 1 are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 86 completed trials in University of Hawaii, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in University of Hawaii, 4 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 23 trials that are defined as “Not Applicable".

University of Hawaii has several departments that took part in Clinical trials: "Department of Native Hawaiian Health, University of Hawaii" - 5 trials, "Diabetes Research Goup University of Hawaii at Manoa" - 4 trials, "Cheryl Albright, PhD, MPH" - 2 trials